Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.

The Lancet. Haematology·2025
Same author

A new ESAIC open access journal.

European journal of anaesthesiology and intensive care·2025
Same author

Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation.

Archives of cardiovascular diseases·2023
Same author

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.

Critical care (London, England)·2023
Same author

Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.

British journal of anaesthesia·2021

Related Experiment Video

Updated: Jun 3, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

[Perioperative venous thromboembolism prophylaxis].

Charles-Marc Samama1

  • 1Service d'anesthésie-réanimation, Hôtel-Dieu, AP-HP, 75181 Paris Cedex 04. marc.samama@htd.aphp.fr

La Revue Du Praticien
|April 2, 2011
PubMed
Summary

Venous thromboembolism prophylaxis reduces surgical risk, with mechanical methods as first-line for bleeding patients. Drug therapy enhances effectiveness, but long-term outcomes require further study.

Area of Science:

  • Medical research
  • Surgical risk assessment
  • Pharmacology

Context:

  • Perioperative management has improved, decreasing surgical risk.
  • Venous thromboembolism (VTE) prophylaxis benefits are established.
  • Mechanical prophylaxis is recommended for patients with bleeding risks.

Purpose:

  • To review current strategies for VTE prophylaxis.
  • To highlight considerations for drug selection and patient risk stratification.
  • To discuss the evolving landscape of antithrombotic agents.

Summary:

  • VTE risk is multifactorial, combining patient and surgical factors.
  • Mechanical prophylaxis is a primary strategy, especially for high-bleeding-risk patients.
  • Pharmacological prophylaxis, considering renal function and patient specifics, enhances efficacy.

Related Experiment Videos

Last Updated: Jun 3, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

  • Extended prophylaxis is recommended for high-risk surgeries like hip replacement and major abdominal procedures.
  • The clinical significance of distal deep vein thromboses is debated, advocating for clinical endpoints over surrogate venographic ones.
  • New oral anticoagulants present future challenges regarding monitoring and reversal.
  • Impact:

    • Informs clinical practice regarding VTE prophylaxis selection and duration.
    • Highlights the need for individualized risk assessment and management.
    • Suggests a shift towards clinical criteria for evaluating prophylaxis effectiveness.
    • Anticipates changes in VTE prevention strategies with novel oral antithrombotic agents.